| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Naoki Mori | |
| Masachika Senba | |||
| P2860 | cites work | Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis | Q22253275 |
| The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 | Q24317677 | ||
| A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer | Q24555647 | ||
| A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions | Q24599668 | ||
| The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. | Q51968734 | ||
| A rat cytomegalovirus strain with a disruption of the r144 MHC class I-like gene is attenuated in the acute phase of infection in neonatal rats. | Q52546212 | ||
| Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines. | Q53280266 | ||
| Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. | Q53435227 | ||
| Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. | Q54765914 | ||
| Carcinogenicity of human papillomaviruses | Q58296516 | ||
| Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+T Lymphocytes in Human Cervical Carcinoma | Q58377175 | ||
| Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 | Q60321491 | ||
| Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study | Q64131548 | ||
| VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2 | Q64378091 | ||
| Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB | Q64381570 | ||
| Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III | Q64382267 | ||
| Partial characterization of viral DNA from human genital warts (condylomata acuminata) | Q72849622 | ||
| HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A | Q72941551 | ||
| Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes | Q73526578 | ||
| Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions | Q73642676 | ||
| Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia | Q73689490 | ||
| A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses | Q84325940 | ||
| The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand | Q39445957 | ||
| Molecular cloning of viral DNA from human genital warts. | Q40144734 | ||
| High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. | Q40475356 | ||
| Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins | Q40588089 | ||
| Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes | Q40717026 | ||
| The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex | Q40734787 | ||
| The biology of human papillomaviruses: from warts to cancer. | Q40742717 | ||
| Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer | Q40788937 | ||
| Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. | Q40879610 | ||
| Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium | Q41003041 | ||
| Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis | Q41071971 | ||
| Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. | Q41073362 | ||
| The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. | Q41083877 | ||
| E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. | Q41158814 | ||
| Papillomavirus infections--a major cause of human cancers | Q41159507 | ||
| The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region | Q41353765 | ||
| Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network | Q41668848 | ||
| Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator | Q41710155 | ||
| Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens | Q41750984 | ||
| Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner | Q42424926 | ||
| The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. | Q42648852 | ||
| The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. | Q42694501 | ||
| Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein | Q42806297 | ||
| Association of human papillomavirus types 16 and 18 E6 proteins with p53. | Q43701619 | ||
| Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. | Q44625801 | ||
| Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. | Q45750788 | ||
| Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome | Q45750789 | ||
| Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide | Q46273868 | ||
| Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix | Q48008896 | ||
| Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity | Q24599944 | ||
| The NLR gene family: a standard nomenclature | Q24645445 | ||
| Inflammation and cancer | Q24649640 | ||
| Innate immune recognition | Q27860721 | ||
| Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis | Q28143403 | ||
| Assembly and export of MHC class I peptide ligands | Q28218643 | ||
| The papillomavirus life cycle | Q28238578 | ||
| The IkappaB kinase - a bridge between inflammation and cancer | Q28270208 | ||
| Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia | Q28296557 | ||
| NF-kappaB and IKK as therapeutic targets in cancer | Q28297985 | ||
| Modulation of NF-κB signalling by microbial pathogens | Q28709497 | ||
| The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
| Papillomaviruses and cancer: from basic studies to clinical application | Q29614745 | ||
| Pathogen recognition by the innate immune system | Q29615592 | ||
| Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
| Regulation and function of NF-kappaB transcription factors in the immune system | Q29616427 | ||
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Classification of papillomaviruses | Q29618731 | ||
| Inflammation meets cancer, with NF-κB as the matchmaker | Q29620242 | ||
| Microbial manipulation of receptor crosstalk in innate immunity | Q30499616 | ||
| Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. | Q33292294 | ||
| The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha | Q33292312 | ||
| Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product | Q33589833 | ||
| Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins | Q33611284 | ||
| Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions | Q33784825 | ||
| The role of the E6-p53 interaction in the molecular pathogenesis of HPV. | Q33807833 | ||
| Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes | Q33839638 | ||
| Tumor immunology--when a cancer cell meets the immune cells | Q33855850 | ||
| Natural killer cells, viruses and cancer | Q34119645 | ||
| Polymorphisms in Toll-like receptor genes and risk of cancer | Q37051040 | ||
| Immune evasion of natural killer cells by viruses | Q37060710 | ||
| Tumour immunity: effector response to tumour and role of the microenvironment | Q37085136 | ||
| Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. | Q37088488 | ||
| Innate immune response to viral infection | Q37241258 | ||
| Insights into Langerhans cell function from Langerhans cell ablation models | Q37268972 | ||
| Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles | Q37279489 | ||
| NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome | Q37307112 | ||
| Viral evasion and subversion of pattern-recognition receptor signalling | Q37319381 | ||
| Papillomaviruses in the causation of human cancers - a brief historical account | Q37365856 | ||
| The roles of TLRs, RLRs and NLRs in pathogen recognition | Q37402176 | ||
| NF-kappaB as a critical link between inflammation and cancer | Q37412699 | ||
| The epidemiology behind the HPV vaccine discovery | Q37432591 | ||
| Human papillomavirus prevalence and type distribution in penile carcinoma | Q37586655 | ||
| Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases | Q37621248 | ||
| Recognition of viral nucleic acids in innate immunity | Q37664675 | ||
| The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
| Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. | Q37700833 | ||
| Pathology and epidemiology of HPV infection in females | Q37715406 | ||
| The Battle between Virus and Host: Modulation of Toll-Like Receptor Signaling Pathways by Virus Infection | Q37776665 | ||
| Viral evasion of T cell immunity: ancient mechanisms offering new applications | Q37819118 | ||
| Pattern recognition receptors and the innate immune response to viral infection | Q37945230 | ||
| Linear ubiquitination: a novel NF-κB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex | Q38016706 | ||
| Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection | Q38309265 | ||
| Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer | Q39445934 | ||
| Detection of Human papillomavirus and cellular regulators p16INK4a, p53, and NF-kappaB in penile cancer cases in Kenya. | Q39445949 | ||
| Regulation of proliferation, survival and apoptosis by members of the TNF superfamily | Q34269354 | ||
| Human papillomaviruses. | Q34316350 | ||
| Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest | Q34357109 | ||
| Chapter 1: HPV in the etiology of human cancer | Q34562937 | ||
| Immune evasion in human papillomavirus-associated cervical cancer | Q34570129 | ||
| Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein | Q34742793 | ||
| Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells | Q34887778 | ||
| The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells | Q34973887 | ||
| Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains | Q35036645 | ||
| Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis | Q35082804 | ||
| Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation | Q35196630 | ||
| NF-κB in immunobiology. | Q35348282 | ||
| Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b | Q35888022 | ||
| Mechanisms of human papillomavirus-induced oncogenesis. | Q35915935 | ||
| Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames | Q35921639 | ||
| The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses | Q36064290 | ||
| Viral interference with MHC class I antigen presentation pathway: the battle continues | Q36174914 | ||
| Human papillomavirus genotypes in penile cancers from Japanese patients and HPV-induced NF-κB activation | Q36216805 | ||
| Relationship among human papillomavirus infection, p16(INK4a), p53 and NF-κB activation in penile cancer from northern Thailand | Q36217010 | ||
| Natural killer cell immune responses | Q36232756 | ||
| Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus | Q36371228 | ||
| Chapter 2: The burden of HPV-related cancers | Q36584354 | ||
| The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. | Q36636087 | ||
| Antiviral signaling through pattern recognition receptors | Q36693188 | ||
| Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins | Q36695353 | ||
| Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway | Q36705250 | ||
| Mechanisms used by human papillomaviruses to escape the host immune response. | Q36737715 | ||
| Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia | Q36794745 | ||
| Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16 | Q36829187 | ||
| Innate recognition of viruses | Q36950601 | ||
| Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells | Q37051030 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| human papillomavirus infection | Q184627 | ||
| Papillomavirus | Q1137717 | ||
| evasion of host immune response | Q1660157 | ||
| P304 | page(s) | e17 | |
| P577 | publication date | 2012-10-02 | |
| P1433 | published in | Oncology reviews | Q26841967 |
| P1476 | title | Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection | |
| P478 | volume | 6 |
| Q41341601 | Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis |
| Q64914998 | Expression of PD-L1 in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression. |
| Q47159047 | How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery |
| Q57475463 | Innate immunity and HPV: friends or foes |
| Q35042272 | Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). |
| Q37586829 | Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma |
| Q37182781 | PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy |
| Q89100195 | Sipi soup inhibits cancer‑associated fibroblast activation and the inflammatory process by downregulating long non‑coding RNA HIPK1‑AS |
Search more.